{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:05:37Z","timestamp":1790132737201,"version":"4.0.1"},"reference-count":13,"publisher":"Informa UK Limited","issue":"12","funder":[{"DOI":"10.13039\/501100004433","name":"Chinese Pharmaceutical Association","doi-asserted-by":"publisher","award":["CPA-Z05-ZC-2022-003"],"award-info":[{"award-number":["CPA-Z05-ZC-2022-003"]}],"id":[{"id":"10.13039\/501100004433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/14740338.2023.2248872","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:58:15Z","timestamp":1695085095000},"page":"1317-1320","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Janus kinase inhibitor\u2014Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-9453","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"first","affiliation":[{"name":"Clinical Trial Center, Peking University International Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-523X","authenticated-orcid":false,"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"XELJANZ\u00ae (tofacitinib) [Internet]. [cited 2022 Dec 13]. [Internet] https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/203214s028 208246s013 213082s003lbl.pdf"},{"key":"e_1_3_5_3_1","unstructured":"OLUMIANT (baricitinib) [Internet]. [cited 2022 Dec 13]. [Internet] https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207924s007lbl.pdf"},{"key":"e_1_3_5_4_1","unstructured":"RINVOQ\u00ae (upadacitinib) [Internet]. [cited 2022 Dec 13]. [Internet] https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/211675s010lbl.pdf"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.24"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.5.929"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00754.x"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3691"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.537"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1964-1"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2011.07793.x"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2007.06424.x"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30155"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2248872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:40:42Z","timestamp":1727185242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2248872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/14740338.2023.2248872"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2248872","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}